Product Description
by Ken R. Harewood (Author)
This book draws attention to one of the most groundbreaking scientific advances of the twentieth century-James Watson's seminal report on the structure of DNA. Based on his extensive experience in discovery research, the author shows how American scientists used information revealed in Watson's report to 'crack' the genetic code, sequence the human genome, and spin-off an industry that propelled America to a position of global leadership in science and technology. The narrative Illustrates how dominance in Biotech forced America's colleges and universities to embrace a new paradigm for training the next generation of scientific innovators. In addressing this challenge, the author provides an historical perspective on the development of the American education system; highlights the struggles that Blacks faced to integrate that system; and identifies actions that could be taken to strengthen and expand Americas science education pipeline. The narrative concludes with a discussion of the negative impact that increasing tuition costs and escalating debt are having on student enrollment. The author believes that the proliferation of online courses at some colleges and universities is an attractive options for students to access degree offerings at lower costs.
Author Biography
Dr. Ken Harewood, GCM, formerly GlaxoSmithKline's Distinguished Professor, Director of the North Carolina Central University (NCCU) Julius L. Chambers Biomedical/Biotechnology Research Institute, and Adjunct Professor, Department of Molecular Genetics and Microbiology, Duke University, is widely recognized for his contribution in the areas of cancer biology and cancer drug discovery. Dr. Harewood received his secondary education at the Lodge School, Barbados, where in addition to academics, he excelled at soccer, becoming team captain and a member of the Barbados National Soccer Team. He attended New York University where he earned a Bachelor's degree in Biology. He received his Masters and Doctoral degrees in Biochemistry from City College of the City University of New York. After completing post-doctoral training at the New York Blood Center, Dr. Harewood joined the Central Research Division of Pfizer Inc. where he served as project leader in the Cancer Research Department and Principal Research Investigator in the Department of Molecular Genetics. Dr. Harewood's extensive corporate research experience resulted in creative contributions to national and international efforts that culminated in the discovery of the first human leukemia virus as well as the virus that causes AIDS. He conducted pioneering work on cloning the gene for bovine calf rennin leading to FDA approval of the first recombinant DNA process for a food ingredient. He also developed innovative cell-based strategies to facilitate the discovery of novel drugs to treat cancer. Dr. Harewood's high level of recognition is evidenced by the numerous honors and awards he received. These include: the Harlem YMCA Black Achievers in Industry Award; the National Consortium for Black Professional Development Health Sciences Award; the 1998 Barbados Charity Fund Pride and Industry Award; the 2006 North Carolina Central University Chancellor's Merit Award; the 2006 University of North Carolina Oliver Max Gardner Award; and the Barbados Gold Crown of Merit Award.
